The Price of Global Health: Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation

★★★★★ 4.6 115 Bewertungen

€49.14
Preis bei Onlinekauf
Kostenloser Versand 30 Tage kostenlose Rückgabe

Verkauft und versendet von www.agenciacoranto.com.ar
Wir bemühen uns, Ihnen genaue Produktinformationen anzuzeigen. Hersteller, Lieferanten und andere stellen die hier gezeigten Angaben bereit.
€49.14
Preis bei Onlinekauf
Kostenloser Versand 30 Tage kostenlose Rückgabe

Wie möchten Sie Ihren Artikel erhalten?
Die ersten 30 Tage sind kostenlos! Wählen Sie den Tarif an der Kasse.
Versand
Ankunft 19.10.
Kostenlos
Abholung
In der Nähe prüfen
Lieferung
Nicht verfügbar

Verkauft und versendet von www.agenciacoranto.com.ar
30 Tage kostenlose Rückgabe Details

Produktdetails

Artikelnummer 232016383 Erscheinungsdatum 2026/06/18 Listenpreis €49.14 Modellnummer 232016383
Kategorie

The Price of Global Health is a unique book that describes the pharmaceutical pricing process and its business, economic and social challenges. Global drug pricing is one of the most hotly debated yet least understood aspects of the pharmaceutical industry. How should drug prices be set and what does it mean for patients? Why do governments increasingly get involved, and what is its impact on the global competitive environment? How can a life-saving industry have a poorer image than gun and tobacco industries, whose products are associated with death?The pharmaceutical industry is under unprecedented pressure due to a combination of declining R&D productivity, payer/provider demands for better value and public pressures to show pricing restraint. Rapidly increasing cost of healthcare, shifts from fee-for-service to value-based reimbursement, public pressure on drug pricing and an increasingly vocal medical community have empowered public and private payers worldwide to be more demanding on evidence of value for the prescription drugs that are brought to market. Pharmaceutical companies have often failed to deliver evidence of patient value, as development decision-making is overly focused on speed to FDA approval rather than speed to commercial success by effectively addressing the many “Access Journey” obstacles that typify today’s much changed pharmaceutical environment.This 3rd edition is significantly expanded with ten new chapters and revised and updated throughout to reflect today’s environment. The contents are reorganized to directly address critical pricing and patient access issues. Ed Schoonveld explains how pharmaceutical prices are determined in a complex global payer environment and what factors influence the process. His insights will help a wide range of audiences from healthcare industry professionals to policy makers, consumers, pharmaceutical company leaders and access and pricing professionals to gain a better understanding of this highly complex and emotionally charged field. Read more

ISBN10 0367279401
ISBN13 978-0367279400
Edition 3rd
Language English
Publisher Routledge
Dimensions 7 x 1.25 x 9.75 inches
Item Weight 3.45 pounds
Print length 626 pages
Publication date June 3, 2020

Korrektur der Produktinformationen

Wenn Sie Unvollständigkeiten oder Fehler in den Produktinformationen auf dieser Seite bemerken, nutzen Sie bitte das Korrekturformular unten.

Korrekturanfrage

Kundenbewertungen

4.6 von 5
★★★★★
115 Bewertungen | 47 Rezensionen
So wird die Artikelbewertung berechnet
Alle Bewertungen anzeigen
5 Sterne
84% (97)
4 Sterne
3% (3)
3 Sterne
2% (2)
2 Sterne
1% (1)
1 Stern
10% (12)
Sortieren nach

Für dieses Produkt liegen derzeit keine schriftlichen Bewertungen vor.